Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

INGN

Inogen Inc

Oct 04 • 10:01AM ET

9.23

Dollar change -0.02
Percentage change -0.16	%

Healthcare • Medical Devices • USA • NASD

Held by: VTI IWM VXF IWN VTWO VHT PRFZ IWC AVSC DFAS

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.97	Insider Own	1.55%	Shs Outstand	23.72M	Perf Week	-4.70%
Market Cap	219.05M	Forward P/E	-	EPS next Y	-1.68	Insider Trans	-2.65%	Shs Float	23.35M	Perf Month	-21.07%
Income	-92.44M	PEG	-	EPS next Q	-0.50	Inst Own	91.74%	Short Float	4.18%	Perf Quarter	4.71%
Sales	326.65M	P/S	0.67	EPS this Y	56.47%	Inst Trans	-0.04%	Short Ratio	4.74	Perf Half Y	46.59%
Book/sh	7.91	P/B	1.17	EPS next Y	12.44%	ROA	-27.06%	Short Interest	0.98M	Perf Year	86.94%
Cash/sh	5.11	P/C	1.81	EPS next 5Y	-	ROE	-39.99%	52W Range	4.13 - 13.33	Perf YTD	68.21%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-44.94%	52W High	-30.72%	Beta	1.04
Dividend TTM	-	Quick Ratio	2.37	Sales past 5Y	-1.72%	Gross Margin	45.69%	52W Low	123.61%	ATR (14)	0.46
Dividend Ex-Date	-	Current Ratio	2.70	EPS Y/Y TTM	5.41%	Oper. Margin	-16.91%	RSI (14)	25.18	Volatility	4.44% 4.32%
Employees	834	Debt/Eq	0.11	Sales Y/Y TTM	-6.48%	Profit Margin	-28.30%	Recom	3.00	Target Price	9.50
Option/Short	Yes / Yes	LT Debt/Eq	0.10	EPS Q/Q	44.24%	Payout	-	Rel Volume	0.29	Prev Close	9.25
Sales Surprise	7.59%	EPS Surprise	48.30%	Sales Q/Q	6.13%	Earnings	Aug 06 AMC	Avg Volume	205.76K	Price	9.23
SMA20	-11.95%	SMA50	-15.89%	SMA200	10.53%	Trades		Volume	7,469	Change	-0.16%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-15-24	Upgrade	William Blair	Mkt Perform → Outperform
Aug-08-23	Downgrade	JP Morgan	Overweight → Neutral	$15 → $8
Jul-14-23	Downgrade	Needham	Buy → Hold
Jan-17-23	Downgrade	William Blair	Outperform → Mkt Perform
Dec-09-21	Upgrade	Needham	Hold → Buy	$47
Nov-02-21	Upgrade	JP Morgan	Underweight → Neutral	$45
Aug-05-21	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Jun-04-21	Upgrade	William Blair	Mkt Perform → Outperform
Dec-14-20	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$60
Jul-23-20	Downgrade	Needham	Buy → Hold
May-06-20	Reiterated	Needham	Buy	$80 → $75
Nov-06-19	Upgrade	Needham	Hold → Buy	$90
Sep-13-19	Reiterated	Piper Jaffray	Overweight	$80 → $80
Aug-08-19	Downgrade	SVB Leerink	Outperform → Mkt Perform	$78 → $47
Aug-08-19	Downgrade	Stifel	Buy → Hold
Aug-07-19	Downgrade	Needham	Buy → Hold
Jun-28-19	Downgrade	Needham	Strong Buy → Buy	$111 → $91
May-08-19	Reiterated	Needham	Strong Buy	$191 → $111
May-08-19	Downgrade	JP Morgan	Overweight → Neutral	$175 → $72
Feb-27-19	Reiterated	Needham	Strong Buy	$280 → $191

Show Previous Ratings

Sep-05-24 08:30AM	Inogen Appoints Eric Pauls as Vice President of Sales, North America (Business Wire)
Aug-22-24 01:16PM	Inogen (INGN) Rises 127% Year to Date: What's Driving the Stock? (Zacks)
Aug-08-24 12:00PM	Inogen (INGN) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks) +5.32%
Aug-07-24 11:34AM	Inogen (INGN) Q2 Earnings Beat Estimates, Revenues Rise Y/Y (Zacks) +35.95%
Aug-06-24 06:05PM	Inogen (INGN) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
05:06PM	Loading…
05:06PM	Inogen: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Inogen Announces Second Quarter 2024 Financial Results (Business Wire)
Jul-22-24 06:24AM	3 Stocks Under $10 With the Potential for Massive Gains (InvestorPlace)
Jul-16-24 08:30AM	Inogen to Report Second Quarter 2024 Financial Results on August 6, 2024 (Business Wire) +6.09%
Jul-15-24 09:00AM	3 Reasons to Retain Inogen (INGN) Stock in Your Portfolio Now (Zacks)
Jul-03-24 04:10PM	Inogen Strengthens Leadership Team with Appointment of New General Counsel and Executive Vice President, Business Development (Business Wire) +5.35%
Jun-06-24 11:31AM	Inogen (INGN) Down 0.1% Since Last Earnings Report: Can It Rebound? (Zacks)
Jun-03-24 04:05PM	Inogen Announces Publication of Study Demonstrating the Association of Portable Oxygen Therapy with Decreased Mortality and Increased Cost-Effectiveness Ratio (Business Wire) -5.28%
May-09-24 01:29PM	Inogen (INGN) Q1 Earnings Top Estimates, Revenues Up Y/Y (Zacks) +5.46%
May-08-24 01:27PM	Inogen, Inc. (NASDAQ:INGN) Q1 2024 Earnings Call Transcript (Insider Monkey) +12.88%
07:14AM	Loading…
07:14AM	Q1 2024 Inogen Inc Earnings Call (Thomson Reuters StreetEvents)
04:07AM	Inogen Inc (INGN) Q1 2024 Earnings Call Transcript Highlights: Navigating Market Dynamics with ... (GuruFocus.com)
May-07-24 09:55PM	INGN Stock Earnings: Inogen Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
08:00PM	Here's What Key Metrics Tell Us About Inogen (INGN) Q1 Earnings (Zacks)
06:33PM	Inogen Inc (INGN) Q1 2024 Earnings: Navigating Challenges with a Focus on Growth (GuruFocus.com)
05:32PM	Inogen: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Inogen Announces First Quarter 2024 Financial Results (Business Wire)
Apr-10-24 08:30AM	Inogen to Report First Quarter 2024 Financial Results on May 7, 2024 (Business Wire)
Mar-28-24 11:30AM	Inogen (INGN) Up 26.6% Since Last Earnings Report: Can It Continue? (Zacks)
11:26AM	3 Reasons to Retain Inogen (INGN) Stock in Your Portfolio (Zacks)
Mar-25-24 08:30AM	Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference (Business Wire) +6.36%
Mar-07-24 04:00PM	Inogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (Business Wire) +7.25%
Feb-29-24 08:28AM	Inogen, Inc. (NASDAQ:INGN) Q4 2023 Earnings Call Transcript (Insider Monkey) +5.72%
Feb-28-24 09:22AM	Inogen (INGN) Q4 Earnings Miss Estimates, Gross Margin Improves (Zacks) -32.66%
06:47AM	Q4 2023 Inogen Inc Earnings Call (Thomson Reuters StreetEvents)
07:30PM	Loading…
Feb-27-24 07:30PM	Inogen (INGN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
06:25PM	Inogen (INGN) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
05:30PM	Inogen: Q4 Earnings Snapshot (Associated Press Finance)
04:48PM	Inogen Inc (INGN) Reports Decline in 2023 Revenue and Widening Net Loss (GuruFocus.com)
04:05PM	Inogen Announces Fourth Quarter and Full-Year 2023 Financial Results (Business Wire)
Feb-26-24 09:15AM	Gear Up for Inogen (INGN) Q4 Earnings: Wall Street Estimates for Key Metrics (Zacks)
Feb-23-24 09:00AM	3 Reasons to Hold Inogen (INGN) Stock in Your Portfolio for Now (Zacks)
Feb-01-24 07:03AM	Inogen (INGN) Surges 12.3%: Is This an Indication of Further Gains? (Zacks)
Jan-30-24 04:00PM	Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024 (Business Wire) +5.58% +12.31%
Jan-24-24 04:00PM	Inogen Names Michael Bourque as New Chief Financial Officer (Business Wire) +5.82%
Jan-08-24 07:10AM	Inogen (INGN) Soars 15.4%: Is Further Upside Left in the Stock? (Zacks) +7.66%
Jan-02-24 09:29AM	3 Reasons to Hold Inogen (INGN) Stock in Your Portfolio (Zacks)
Dec-07-23 11:31AM	Inogen (INGN) Down 4.2% Since Last Earnings Report: Can It Rebound? (Zacks) +16.43%
Nov-13-23 08:30AM	Inogen Announces Leadership Change with the Appointment of Kevin Smith as President and CEO (Business Wire)
Nov-10-23 09:30AM	Inogen (INGN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
Nov-09-23 02:30PM	Inogen to Present at Upcoming Investor Conferences in November 2023 (Business Wire) -7.68%
Nov-08-23 11:09AM	Inogen (INGN) Q3 Earnings Miss Estimates, Revenues Down Y/Y (Zacks)
09:57AM	Inogen, Inc. (NASDAQ:INGN) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-07-23 04:36PM	Inogen: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Inogen Announces Third Quarter 2023 Financial Results (Business Wire)
Oct-16-23 09:55AM	Here's Why Inogen (INGN) Is a Great 'Buy the Bottom' Stock Now (Zacks) +6.07%
Oct-13-23 09:35AM	Inogen (INGN) Loses -24.08% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Oct-10-23 04:00PM	Inogen to Report Third Quarter 2023 Financial Results on November 7, 2023 (Business Wire) +6.27%
Oct-09-23 11:15AM	3 Reasons to Retain Inogen (INGN) Stock in Your Portfolio (Zacks)
Sep-18-23 08:30AM	Inogen Completes Acquisition of Physio-Assist (Business Wire)
Sep-07-23 08:30AM	Inogen Announces CFO Transition Plan (Business Wire)
Aug-08-23 11:40AM	Inogen (INGN) Q2 Earnings Beat Estimates, Revenues Down Y/Y (Zacks) -13.60%
08:30AM	Inogen Recognized as a Finalist for Ragan's CSR & Diversity Awards Program (Business Wire)
06:07AM	Q2 2023 Inogen Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-07-23 08:30PM	Here's What Key Metrics Tell Us About Inogen (INGN) Q2 Earnings (Zacks)
05:25PM	Inogen (INGN) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:14PM	Inogen: Q2 Earnings Snapshot (AP Finance)
04:01PM	Inogen Announces Second Quarter 2023 Financial Results (Business Wire)
08:30AM	Inogen Achieves Best In Class 8-Year Expected Service Life Portable Oxygen Concentrators (Business Wire)
Jul-17-23 12:46PM	Inogen (INGN) Inks Buyout Agreement to Expand Product Portfolio (Zacks)
Jul-14-23 11:01AM	Inogen's (INGN) Preliminary Q2 Revenues Dampened by Lower Sales (Zacks) -13.35%
Jul-13-23 08:30AM	Inogen Expands Its Respiratory Product Portfolio with Acquisition of Physio-Assist (Business Wire)
Jul-12-23 06:58AM	Inogen, Inc. (NASDAQ:INGN) is largely controlled by institutional shareholders who own 89% of the company (Simply Wall St.)
Jun-02-23 06:46PM	Palo Alto Networks Set to S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 (PR Newswire) -7.49%
May-18-23 04:53PM	Hero or Zero? 7 Speculative Small-Cap Stocks to Make You Rich or Broke. (InvestorPlace)
May-16-23 06:26AM	Will the Current Downturn Affect Inogen (INGN)? (Insider Monkey)
May-15-23 05:37PM	Inogen to Present at 43rd Annual William Blair Growth Stock Conference (Business Wire)
May-05-23 11:29AM	Inogen (INGN) Q1 Earnings Beat Estimates, Revenues Lag (Zacks) -5.38%
May-04-23 07:00PM	Here's What Key Metrics Tell Us About Inogen (INGN) Q1 Earnings (Zacks)
06:15PM	Inogen (INGN) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
05:06PM	Inogen: Q1 Earnings Snapshot (AP Finance)
04:05PM	Inogen Announces First Quarter 2023 Financial Results (Business Wire)
Apr-26-23 08:00PM	INGN: What does Argus have to say about INGN? (Argus Research)
Apr-21-23 02:37PM	10 Best Humane Stocks to Buy Now (Insider Monkey)
Apr-18-23 07:31AM	A Look At The Fair Value Of Inogen, Inc. (NASDAQ:INGN) (Simply Wall St.)
Apr-06-23 04:05PM	Inogen to Report First Quarter 2023 Financial Results on May 4, 2023 (Business Wire)
Apr-04-23 06:09PM	Inogen to Present at 22nd Annual Needham Virtual Healthcare Conference (Business Wire)
Mar-27-23 01:22PM	At US$12.41, Is Inogen, Inc. (NASDAQ:INGN) Worth Looking At Closely? (Simply Wall St.)
10:22AM	Here's Why You Should Retain Inogen (INGN) Stock for Now (Zacks)
Mar-22-23 04:05PM	Inogen Announces Appointment of Tom West to Board of Directors and Retirement of Board Member Kristen Miranda (Business Wire)
08:24AM	Strength Seen in Inogen (INGN): Can Its 5.0% Jump Turn into More Strength? (Zacks)
Mar-08-23 08:30AM	Inogen to Present at KeyBanc Life Sciences & MedTech Investor Forum (Business Wire)
Mar-07-23 05:50AM	We're Keeping An Eye On Inogen's (NASDAQ:INGN) Cash Burn Rate (Simply Wall St.)
Feb-24-23 11:03AM	Inogen (INGN) Q4 Earnings Beat Estimates, Revenues Lag (Zacks) -31.39%
Feb-23-23 04:10PM	Inogen to Provide Strategy Update on February 27, 2023 (Business Wire)
04:02PM	Inogen Announces Fourth Quarter and Full Year 2022 Financial Results (Business Wire)
Feb-22-23 06:13AM	3 Reasons to Retain Inogen (INGN) Stock in Your Portfolio (Zacks)
Feb-20-23 10:00AM	Analysts Estimate Inari Medical, Inc. (NARI) to Report a Decline in Earnings: What to Look Out for (Zacks)
Feb-16-23 10:01AM	Inogen (INGN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Feb-03-23 08:02AM	Investors in Inogen (NASDAQ:INGN) from five years ago are still down 78%, even after 12% gain this past week (Simply Wall St.)
Jan-13-23 08:23AM	Inogen (INGN) Announces Solid Preliminary Q4 Revenues (Zacks)
Jan-10-23 08:30AM	Inogen Achieves Regulatory Milestones to Support Current and Future Products (Business Wire)
08:00AM	Inogen Announces Preliminary Fourth Quarter and Full Year 2022 Revenue Within Company Expectations (Business Wire)
Dec-27-22 10:49AM	3 Reasons to Retain Inogen (INGN) Stock in Your Portfolio (Zacks)
Dec-13-22 04:00PM	Inogen to Present at 41st Annual J.P. Morgan Healthcare Conference (Business Wire)

Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its products include Inogen One G4 system, Inogen One G3 system, Inogen One G5 system, Inogen TAV, and Inogen at Home. The company was founded by Alison Perry, Alison K. Bauerlein, Brenton Taylor, and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
JASON SOMER	Officer	Aug 09 '24	Proposed Sale	12.03	4,690	56,423		Aug 09 04:53 PM
Somer Jason	EVP, Gen. Counsel & Secretary	Jun 01 '24	Option Exercise	0.00	577	0	5,029	Jun 04 05:08 PM
Somer Jason	EVP, Gen. Counsel & Secretary	May 10 '24	Sale	8.56	10,000	85,600	4,452	May 14 06:43 PM
Somer Jason	EVP, Gen. Counsel & Secretary	May 01 '24	Option Exercise	0.00	19,276	0	25,764	May 03 06:15 PM
Glezer Stanislav	EVP, R&D & Chief Med. Officer	May 01 '24	Option Exercise	0.00	32,638	0	48,744	May 03 06:14 PM
Somer Jason	EVP, Gen. Counsel & Secretary	Mar 01 '24	Option Exercise	0.00	7,150	0	11,064	Mar 05 07:10 PM
Glezer Stanislav	EVP, R&D & Chief Med. Officer	Mar 01 '24	Option Exercise	0.00	13,914	0	23,729	Mar 05 07:08 PM
Somer Jason	EVP, Gen. Counsel & Secretary	Dec 01 '23	Option Exercise	0.00	576	0	4,200	Dec 04 06:30 PM
Glezer Stanislav	EVP, Chief Technology Officer	Dec 01 '23	Option Exercise	0.00	4,555	0	12,146	Dec 04 06:29 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

INGN

Inogen Inc

Upgrade your FINVIZ experience